Connect Biopharma Holdings Limited
CNTB · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $60K | $26.0M | −99.8% |
| Operating income | −$58.1M | −$22.4M | −159% |
| Net income | −$55.5M | −$15.6M | −255% |
Questions
- What was Connect Biopharma's revenue in FY2025?
- $60K in FY2025 (Fiscal year ended Dec 31, 2025), −99.8% vs $26.0M a year earlier, per its 10-K filed Mar 2026.
- Was Connect Biopharma profitable in FY2025?
- No: net income was −$55.5M and operating income −$58.1M in FY2025.